1. Panels of mRNAs and miRNAs for decoding molecular mechanisms of Renal Cell Carcinoma (RCC) subtypes utilizing Artificial Intelligence approaches
   Seyed Mahdi Hosseiniyan Khatibi et al, 2022, Scientific Reports CrossRef
2. Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma
   Jianxiang Zhang et al, 2023, Frontiers in Pharmacology CrossRef
3. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation
   Xiao Li et al, 2023, BMC Cancer CrossRef
4. Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma
   Huihui Zhao et al, 2022, Frontiers in Genetics CrossRef
5. The interaction network of the proteasome assembly chaperone PSMD9 regulates proteostasis
   Joel Christie et al, 2023, The FEBS Journal CrossRef
6. Integrated genomic analysis of proteasome alterations across 11,057 patients with 33 cancer types: clinically relevant outcomes in framework of 3P medicine
   Na Li et al, 2021, EPMA Journal CrossRef
7. Radiotherapy resistance: identifying universal biomarkers for various human cancers
   Irina Larionova et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef